Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL. [electronic resource]
Producer: 20171214Description: 28-33 p. digitalISSN:- 1476-5365
- Adult
- Aged
- Bendamustine Hydrochloride -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- mortality
- Male
- Middle Aged
- Rituximab -- administration & dosage
- Survival Rate
- Transplantation Conditioning -- methods
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.